The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CfDNA NGS detection of fusions acquired as mechanisms of resistance in the post-EGFR setting across multiple solid tumors.
 
Arielle Yablonovitch
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Patents, Royalties, Other Intellectual Property - Patent application filed with Guardant Health
Travel, Accommodations, Expenses - Guardant Health
 
Nicole Zhang
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Patents, Royalties, Other Intellectual Property - RWE selection patent application pending
Travel, Accommodations, Expenses - Guardant Health
 
Leylah Drusbosky
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Travel, Accommodations, Expenses - Guardant Health
 
Reagan Barnett
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Consulting or Advisory Role - InVitro Cell Research
 
Jennifer Yen
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health; Guardant Health
 
Shile Zhang
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Patents, Royalties, Other Intellectual Property - Illumina
 
Han-Yu Chuang
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Patents, Royalties, Other Intellectual Property - Guardant Health; Illumina
 
Scott Kopetz
Stock and Other Ownership Interests - Frontier Medicines; Iylon; Lutris; Navire; Xilis
Consulting or Advisory Role - Abbvie; Accademia Nazionale Di Medicina (ACCMED); Amal Therapeutics; Amgen; AstraZeneca/MedImmune; Bayer Health; Bicara Therapeutics; Black Diamond Therapeutics; Boehringer Ingelheim; Bristol-Myers Squibb/Medarex; Cardiff Oncology; Carina Biotech; CureTeq; EMD Serono; Endeavor BioMedicines; Flame Biosciences; Foundation Medicine; Frontier Medicines; Genentech; Genomic Health; Gilead Sciences; GlaxoSmithKline; HalioDx; Harbinger Oncology, Inc; Holy Stone Healthcare; Inivata; Ipsen; Iylon; Jacobio; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Lilly; Lutris; Merck; Mirati Therapeutics; NeoGenomics Laboratories; Novartis; Numab; Ono Pharmaceutical; Pfizer; Redx Pharma; Repare Therapeutics; Replimune; Servier; Taiho Pharmaceutical; Takeda; Tempus; Xilis; Zentalis
Research Funding - Amgen; Array BioPharma; Biocartis; Daiichi Sankyo; EMD Serono; Genentech/Roche; Guardant Health; Lilly; MedImmune; Novartis; Sanofi
 
Jonathan M. Loree
Consulting or Advisory Role - Advanced Accelerator Applications; AMGEN; Bayer; Ipsen; Pfizer; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Ipsen (Inst)
 
Van K. Morris
Consulting or Advisory Role - Axiom Healthcare Strategies; Bicara Therapeutics; BioMedical Insights; Boehringer Ingelheim; Incyte
Research Funding - Bicara Therapeutics (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Immatics; Pfizer (Inst)